Exploration of medical cannabinoid-therapies in Germany - an anonymous survey

Exploration of medical cannabinoid-therapies in Germany - an anonymous survey - EXCARP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023344

Enrollment

300

Registered

2021-04-28

Start date

2021-05-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any condition that is currently being treated with prescribed cannabinoids.

Interventions

Group 1: This is an exploratory study. It includes only one sample / group. We are planning to conduct a survey of n=300 patients who are receiving cannabinoid-therapy. The survey is a fully anonymous

Eligibility

Sex/Gender

All

Age

18 Years to 130 Years

Inclusion criteria

Inclusion criteria: -Ongoing therapy with prescription-cannabinoids or prescription-cannabinoid-therapy within the last year. -Internet access. -Kognitive ability to participate in a 45-min survey online. -Informed consent.

Exclusion criteria

Exclusion criteria: Non-consent

Design outcomes

Primary

Measure	Time frame
This is an exploratory study. It does not have one single primary endpoint. Variables include: • Demography (age, occupation, marital status, training, income) • Treatment Satisfaction Questionnaire for Medication (TSQM-II) • Wellbeing (WHO-5) • Patient Reported Outcomes Measurement Information System (PROMIS-29) • Short screening-scale for post traumatic stress disorder DSM-IV • Brief Pain Inventory (BPI) • Face Pain Scale (FPS-R) • Numeric Rating Scale pain (NRS) • MS Spasticity Scale-88 (MSSS-88) • Anorexia Nervosa Inventory (ANIS) • Minimal Documentations-System (MIDOS) • Hospital Anxiety and Depression Scale (HADS) • Adult ADHD Self-Report Scale (ASRS-v1.1) • Substance abuse (alcohol, nicotine, etc.)	—

Measure

Time frame

This is an exploratory study. It does not have one single primary endpoint. Variables include: • Demography (age, occupation, marital status, training, income) • Treatment Satisfaction Questionnaire for Medication (TSQM-II) • Wellbeing (WHO-5) • Patient Reported Outcomes Measurement Information System (PROMIS-29) • Short screening-scale for post traumatic stress disorder DSM-IV • Brief Pain Inventory (BPI) • Face Pain Scale (FPS-R) • Numeric Rating Scale pain (NRS) • MS Spasticity Scale-88 (MSSS-88) • Anorexia Nervosa Inventory (ANIS) • Minimal Documentations-System (MIDOS) • Hospital Anxiety and Depression Scale (HADS) • Adult ADHD Self-Report Scale (ASRS-v1.1) • Substance abuse (alcohol, nicotine, etc.)

—

Countries

Germany

Contacts

Public ContactNadine Sylvester

Immanuel Krankenhaus Berlin, Zentrum für Naturheilkunde und Hochschulambulanz für Naturheilkunde der Charité Universitätsmedizin Berlin am Standort Immanuel Krankenhaus

naturheilkunde@immanuel.de030-80505-691

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026